![Gary Woodnutt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historique de carrière de Gary Woodnutt
Anciens postes connus de Gary Woodnutt
Sociétés | Poste | Début | Fin |
---|---|---|---|
CONTRAFECT CORPORATION | Corporate Officer/Principal | 17/06/2021 | 04/12/2023 |
Lpath, Inc.
![]() Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Directeur Technique/Scientifique/R&D | 16/04/2013 | 14/10/2016 |
Tanabe Research Laboratories U.S.A., Inc.
![]() Tanabe Research Laboratories U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Part of Mitsubishi Chemical Group Corp., Tanabe Research Laboratories U.S.A., Inc. develops pharmaceutical products. The company is based in San Diego, CA. | Directeur Technique/Scientifique/R&D | - | - |
Formation de Gary Woodnutt
The University of Reading | Doctorate Degree |
University of Leeds | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Royaume-Uni | 3 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
CONTRAFECT CORPORATION | Health Technology |
Entreprise privées | 2 |
---|---|
Lpath, Inc.
![]() Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Health Technology |
Tanabe Research Laboratories U.S.A., Inc.
![]() Tanabe Research Laboratories U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Part of Mitsubishi Chemical Group Corp., Tanabe Research Laboratories U.S.A., Inc. develops pharmaceutical products. The company is based in San Diego, CA. | Health Technology |
- Bourse
- Insiders
- Gary Woodnutt
- Expérience